Zhejiang Xianju Pharmaceutical News

Xianju Pharmaceutical (002332): Profit increased month-on-month, business continued to advance

China Merchants SecuritiesOct 28 00:00

Xianju Pharmaceutical (002332): Performance is in line with expectations and continues to accelerate, and the trend is expected to continue in 2025

zhongtai SecuritiesOct 27 00:00

Xianju Pharmaceutical (002332): 3Q24 deducts nonprofit growth to accelerate

htscOct 26 00:00

Xianju Pharmaceutical (002332): Pharmaceutical sales are growing steadily, and Omexone sodium is about to be declared

haitong secOct 14 11:01

TF Securities Starts Zhejiang Xianju Pharmaceutical at Buy With 17.37 Yuan Price Target

MT NewswiresOct 11 16:29

Xianju Pharmaceutical (002332): New varieties of leading steroidal full-chain formulations have considerable potential for commercialization

Oct 11 13:21

Xianju Pharmaceutical (002332): Drug Release Recovery Cost Control Improves Profitability

gf secSep 10 00:00

Xianju Pharmaceutical (002332): Optimistic about formulation+innovation to implement the new cycle

Sep 5 07:21

Xianju Pharmaceutical (002332): Innovative muscle loosening antagonist omexone sodium declared NDA

Aug 31 00:00

Xianju Pharmaceutical (002332): H1 has steady performance and new formulations continue to advance

Aug 28 19:01

Xianju Pharmaceutical (002332) 2024 Interim Report Review: The interim report is in line with market expectations and is optimistic that the company's operations will rise to the next level

Aug 27 14:46

Xianju Pharmaceutical (002332): Steroid hormone leader fully upgraded multiple catalysts to create a second growth curve

Aug 1 19:56

Xianju Pharmaceutical (002332): Formulation and API capabilities continue to advance and systematic upgrading brings medium- to long-term competitiveness

May 29 00:00

Xianju Pharmaceutical (002332): Continued dosage of formulations, accelerated internationalization and upgrading of raw materials

May 13 00:00

Xianju Pharmaceutical (002332): Light boat has passed Wanzhongshan to start a new stage of growth

May 11 00:00

Xianju Pharmaceutical (002332): The development of Xiulian Neigong Company ushered in new momentum

May 9 15:31

Xianju Pharmaceutical (002332): Revenue performance in '23 is under pressure, 24Q1 returns to positive growth

May 3 00:00

Xianju Pharmaceutical (002332) Review Report: The company's performance reached an inflection point. Q1 performance in '24 exceeded expectations

Apr 28 20:02

Xianju Pharmaceutical (002332): 2023 results are under pressure, 24Q1 revenue returns to positive growth

Apr 26 00:00

Xianju Pharmaceutical (002332): The impact of mining has passed, 1Q24 results have begun positive growth

Apr 25 10:21